Antibacterial and Antifungal Activities of Andrographolide in Combination with Antimicrobial drugs

Document Type : Original paper


1 Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

2 The Centre for Natural Products Discovery (CNPD), Liverpool John Moores University, Liverpool L3 3AF, England, UK.

3 Department of Biological Sciences, Institute of Structural and Molecular Biology, Birkbeck, University of London, Malet Street, London WC1E 7HX, United Kingdom.

4 Department of Pharmaceutical Science, School of Pharmacy, Central University, Accra, Ghana.


Background and objectives: The resistance of infectious pathogens to antimicrobial drugs is an underestimated threat to public health. This rapidly developing phenomenon necessitates the discovery of new treatment strategies. Combining natural compounds with first-line antimicrobials is one treatment strategy to mitigate the emergence of resistant pathogens. Andrographolide, a diterpene lactone isolated from Andrographis paniculata has been reported to possess potent anti-infective activity. This study was conducted to evaluate the combination effect of andrographolide with first-line antimicrobial drugs to fight emerging resistance. Method: The minimum inhibitory concentration (MIC), fold increase in antimicrobial efficacy and fractional inhibitory concentrations (FIC) of andrographolide and ceftriaxone, ciprofloxacin, amoxicillin, metronidazole, amikacin, clindamycin and fluconazole were determined using the high throughput spot culture growth inhibition (HT-SPOTi) assay against ten isolated clinical strains; Streptococcus pyogenes, Escherichia coli, Vibrio cholerae, Pseudomonas aeruginosa, Staphylococcus aureus, Proteus mirabilis, Klebsiella pneumoniae, Enterococcus faecalis, Salmonella paratyphi B and Candida albicans. Results: Combination of andrographolide and the first-line antimicrobials showed various degrees of susceptibility and efficacy against the tested microorganisms with the highest MIC, 0.85 μg/mL recorded. The FICI (Fractional Inhibitory Concentration Indices) for synergy ranged between 0.00 to 0.28 depending on the microorganism and antimicrobial drug. Conclusion: Use of andrographolide with first-line antimicrobials could aid in combating the menace of resistance pathogens. However, this should be done with caution as some of the antimicrobials tested exhibited antagonistic effects.


Main Subjects

  • Morens DM, Folkers GK, Fauci AS. The challenge of emerging and re-emerging infectious diseases. Nature. 2004; 430(6996): 242–249.
  • Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004; 10(12): 122–129.
  • Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010; 74(3): 417–433.
  • Mittal AK, Bhardwaj R, Mishra P, Rajput SK. Antimicrobials misuse/overuse: adverse effect, mechanism, challenges and strategies to combat resistance. Open Biotechnol J. 2020; 14(1): 107–112.
  • Wagner H, Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomed. 2009; 16 (2–3): 97–110.
  • Hao M, Lv M, Xu H. Andrographolide: synthetic methods and biological activities. Mini Rev Med Chem. 2020; 20(16): 1633–1652.
  • Danquah CA, Maitra A, Gibbons S, Faull J, Bhakta S. HT‐SPOTi: a rapid drug susceptibility test (DST) to evaluate antibiotic resistance profiles and novel chemicals for anti‐infective drug discovery. Curr Protoc Microbiol. 2016; 40(1): 17–18.
  • Kheiralla ZMH, Rushdy AA, Betiha MA, Yakob NAN. High-performance antibacterial of montmorillonite decorated with silver nanoparticles using microwave-assisted method. J Nanoparticle Res. 2014; 16(8): 1–14.
  • Trifan A, Luca SV, Greige-Gerges H, Miron A, Gille E, Aprotosoaie AC. Recent advances in tackling microbial multidrug resistance with essential oils: combinatorial and nano-based strategies. Crit Rev Microbiol. 2020; 46(3): 338–357.
  • Guzman JD, Evangelopoulos D, Gupta A, Birchall K, Mwaigwisya S, Saxty B, McHugh TD, Gibbons S, Malkinson J, Bhakta S. Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay. BMJ Open. 2013; Article ID e002672.
  • Wiegand I, Hilpert K, Hancock R. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008; 3(2): 163–175.
  • Banerjee M, Parai D, Chattopadhyay S, Mukherjee SK. Andrographolide: antibacterial activity against common bacteria of human health concern and possible mechanism of action. Folia Microbiol (Praha). 2017; 62(3): 237–244.
  • Li HT, Qin HM, Wang WH, Li GJ, Wu CM, Song JX. Effect of andrographolide on QS regulating virulence factors production in Pseudomonas aeruginosa. Zhongguo Zhong Yao Za Zhi. 2006; 31(12): 1015–1017.
  • Guo X, Zhang LY, Wu SC, Xia F, Fu YX, Wu YL, Leng CQ, Yi PF, Shen HQ, Wei XB. Andrographolide interferes quorum sensing to reduce cell damage caused by avian pathogenic Escherichia coli. Vet Microbiol. 2014; 174(3–4): 496–503.
  • Wu CM, Cao JL, Zheng MH, Ou Y, Zhang L, Zhu XQ, Song JX. Effect and mechanism of andrographolide on the recovery of Pseudomonas aeruginosa susceptibility to several antibiotics. J Int Med Res. 2008; 36(1): 178–186.
  • Zeng X, Liu X, Bian J, Pei G, Dai H, Polyak SW, Song F, Ma L, Wang Y, Zhang L. Synergistic effect of 14-alpha-lipoyl andrographolide and various antibiotics on the formation of biofilms and production of exopolysaccharide and pyocyanin by Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2011; 55(6): 3015–3017.
  • Majumdar M, Misra TK, Roy DN. In vitro anti-biofilm activity of 14-deoxy-11, 12-didehydroandrographolide from Andrographis paniculata against Pseudomonas aeruginosa. Brazilian J Microbiol. 2020; 51(1): 15–27.
  • Singh U, Akhtar S, Mishra A, Sarkar D. A novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents. J Microbiol Methods. 2011; 84(2): 202–207.
  • Roell KR, Reif DM, Motsinger-Reif AA. An introduction to terminology and methodology of chemical synergy-perspectives from across disciplines. Front Pharmacol. 2017; 8: 1–11.
  • Rousseaux CG, Schachter H. Regulatory issues concerning the safety, efficacy and quality of herbal remedies. Birth Defects Res Part B Dev Reprod Toxicol. 2003; 68(6): 505–510.